Lemonade

Insurtech 100: May - July 2019 quarterly update

Hippo, Lemonade and Zego are just three of the start-ups that have been in the news recently. Matt Connolly, founder and CEO of Tällt Ventures, reflects on a what has been happening for the Insurtech 100 since the list was published in May.

This week: Rolling in it

Thursday seemed an appropriate day for insurtech Hippo to announce the outcome of its latest funding round – with temperatures reaching 38°C in places, the urge to emulate the mud-wallowing tendencies of its namesake animal became more and more tempting.

This week: Dual pricing and sexual harassment claims

For a while now the insurance industry has been under the spotlight for the sheer volume of sexual harassment allegations its faced. And after Post reported this week the suspension of a senior boss at Marsh sister company Guy Carpenter, following…

This week in Post: Funds, loyalty and crime

Gift cards may not be very personal, but they are perfect when you are not sure what to get someone. However, if you are anything like me you put them away in a “safe” place and forget to use them in time.

This month: Seeking the right fit

I’m a fan of making sure stuff is the right fit - I make a point of trying on new outfits in my own home with accessories and shoes to make sure it all works for me. I also test drove my new car a few times to check it was what I wanted. Aon, however,…

Top 100 Insurtech: Quarter four update

It’s time for the final 2018 update on the Insurtech 100, the global index compiled for Post by Tällt Ventures. Here founder and CEO Matt Connolly rounds up the latest investment and partnership news.

This Month in Post: Top 100 teachings

My first three weeks reporting on the insurance industry has taught me how broad the sector is. Covering the claims beat I'm expecting to be learning more about escape of water, floods and storms. Our Top 100 UK insurers ranking has already shown me how…

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: